2023 Key Dates
|2024 Membership Applications|
|2024 Award Nominations||Opens: August 21, 2023
Click Here To Nominate
Closes: September 22, 2023#
|47th Annual Meeting - Registration Now||Opens: September 11, 2023
Click Here To Register
Early Bird 1 Ends: December 3, 2023#
Early Bird 2 Ends: January 3, 2023#
Abstract Submissions for 47th Annual Meeting Opens
|Opens: September 11, 2023
Click Here To Submit Your Abstract
Closes: October 20, 2023#
|Research Grant Applications Open||Opens: October 2, 2023
Closes: November 13, 2023#
# All deadlines are 11:59pm EST for the day indicated
Review the Abstract Submission Guidelines
The Abstract Submission Portal Opens September 11th, 2023
The Macula Society would like to thank you for your past support. The annual Macula Society meetings provide a critical arena for the exchange of cases and groundbreaking advances in research of Retinal Vascular and Macular disease.
Your support makes this possible. Promotional support of this meeting allows access to attend all the Scientific Sessions, Social Events and Awards Presentations with the top leaders in this field from around the world.
The anticipated attendance is 350 people from up to 33 different countries worldwide. This years venue allows for excellent promotional visibility throughout the facility as well as accommodating special opportunities or educational options you may want to pursue.
Please contact firstname.lastname@example.org with any questions.
About the Macula Society
Founded in 1977, the Macula Society is a forum for new research in retinal vascular and macular diseases. Membership is by application, with acceptance criteria including extensive contribution to retinal literature. The Macula Society recognizes outstanding achievement by its members and others through awards and lectures, and holds an annual meeting open to members, their guests, co-authors, and supporting company representatives.
Our email address has changed! Please use
for all future communications!
Judy E. Kim, MD
Mark W. Johnson, MD
Immediate Past President
Glenn J. Jaffee, MD
Macula Society Endowment Fund
The Macula Society Educational Endowment provides a revenue stream to fund various educational initiatives in perpetuity, independent of year-to-year fluctuations in corporate support and other society income sources.
September 7-9, 2023
Santa Clara, California
Join the Interest List at:
The DRCR Retina Network is planning an exciting new Phase III clinical trial to prevent visual acuity loss due to radiation retinopathy (RR). Eligible participants will be randomized to receive either repeated injections of anti-VEGF, long-active steroid, or observation following treatment of choroidal melanoma with I-125 plaque brachytherapy.
Any interested physicians or clinical sites should contact email@example.com to learn more about joining the Network.